Immuneering Net Interest Income vs Net Income From Continuing Ops Analysis

IMRX Stock

USD 1.86 0.04 2.20%

Immuneering Corp financial indicator trend analysis is infinitely more than just investigating Immuneering Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immuneering Corp is a good investment. Please check the relationship between Immuneering Corp Net Interest Income and its Net Income From Continuing Ops accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Net Interest Income vs Net Income From Continuing Ops

Net Interest Income vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immuneering Corp Net Interest Income account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.

The correlation between Immuneering Corp's Net Interest Income and Net Income From Continuing Ops is -0.93. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Immuneering Corp, assuming nothing else is changed. The correlation between historical values of Immuneering Corp's Net Interest Income and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Immuneering Corp are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Net Interest Income i.e., Immuneering Corp's Net Interest Income and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.93

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Net Income From Continuing Ops

Most indicators from Immuneering Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immuneering Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.At this time, Immuneering Corp's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 46.53 in 2025, whereas Selling General Administrative is likely to drop slightly above 10.2 M in 2025.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	51.9M	57.6M	66.3M	37.3M
Cost Of Revenue	158.1K	764.1K	687.7K	732.6K

Total Operating Expenses Cost Of Revenue

Immuneering Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other
Total Assets		-0.81	0.91	0.91	0.98	0.97	0.98	-0.96	-0.81	0.85	0.98	0.97	0.71	1.0	-0.49	0.95	0.62	-0.58	0.94	-0.72	-0.38	0.98	0.63	1.0	0.94	0.44
Short Long Term Debt Total	-0.81		-0.8	-0.84	-0.7	-0.71	-0.81	0.93	0.78	-0.89	-0.89	-0.79	-0.69	-0.81	0.21	-0.77	-0.6	0.11	-0.78	0.41	-0.16	-0.7	-0.67	-0.81	-0.77	-0.44
Other Current Liab	0.91	-0.8		0.99	0.91	0.94	0.98	-0.89	-0.94	0.9	0.94	0.98	0.87	0.89	-0.68	0.99	0.82	-0.63	1.0	-0.44	-0.44	0.91	0.81	0.9	1.0	0.6
Total Current Liabilities	0.91	-0.84	0.99		0.9	0.92	0.97	-0.92	-0.94	0.95	0.96	0.98	0.88	0.9	-0.65	0.98	0.79	-0.58	0.99	-0.47	-0.36	0.9	0.79	0.9	0.98	0.57
Total Stockholder Equity	0.98	-0.7	0.91	0.9		0.99	0.97	-0.9	-0.8	0.8	0.94	0.97	0.7	0.98	-0.59	0.96	0.62	-0.71	0.94	-0.73	-0.54	1.0	0.61	0.98	0.95	0.42
Net Tangible Assets	0.97	-0.71	0.94	0.92	0.99		0.98	-0.9	-0.82	0.81	0.94	0.98	0.73	0.97	-0.61	0.98	0.67	-0.71	0.97	-0.67	-0.55	0.99	0.65	0.97	0.97	0.46
Property Plant And Equipment Net	0.98	-0.81	0.98	0.97	0.97	0.98		-0.95	-0.89	0.9	0.98	1.0	0.81	0.97	-0.62	0.99	0.73	-0.64	0.99	-0.61	-0.44	0.97	0.72	0.97	0.99	0.51
Net Debt	-0.96	0.93	-0.89	-0.92	-0.9	-0.9	-0.95		0.84	-0.92	-0.99	-0.93	-0.74	-0.96	0.42	-0.91	-0.59	0.42	-0.91	0.64	0.17	-0.9	-0.66	-0.96	-0.9	-0.39
Retained Earnings	-0.81	0.78	-0.94	-0.94	-0.8	-0.82	-0.89	0.84		-0.89	-0.86	-0.9	-0.97	-0.79	0.75	-0.89	-0.84	0.61	-0.93	0.23	0.36	-0.8	-0.93	-0.79	-0.92	-0.63
Accounts Payable	0.85	-0.89	0.9	0.95	0.8	0.81	0.9	-0.92	-0.89		0.93	0.89	0.83	0.83	-0.55	0.89	0.67	-0.41	0.9	-0.47	-0.16	0.8	0.7	0.84	0.88	0.49
Cash	0.98	-0.89	0.94	0.96	0.94	0.94	0.98	-0.99	-0.86	0.93		0.97	0.77	0.98	-0.5	0.95	0.67	-0.51	0.95	-0.64	-0.28	0.94	0.69	0.98	0.95	0.48
Non Current Assets Total	0.97	-0.79	0.98	0.98	0.97	0.98	1.0	-0.93	-0.9	0.89	0.97		0.82	0.96	-0.65	1.0	0.74	-0.67	0.99	-0.59	-0.47	0.97	0.74	0.96	0.99	0.53
Non Currrent Assets Other	0.71	-0.69	0.87	0.88	0.7	0.73	0.81	-0.74	-0.97	0.83	0.77	0.82		0.68	-0.81	0.81	0.88	-0.62	0.85	-0.09	-0.38	0.7	0.96	0.69	0.85	0.73
Cash And Short Term Investments	1.0	-0.81	0.89	0.9	0.98	0.97	0.97	-0.96	-0.79	0.83	0.98	0.96	0.68		-0.46	0.94	0.6	-0.56	0.92	-0.74	-0.36	0.98	0.61	1.0	0.92	0.42
Net Receivables	-0.49	0.21	-0.68	-0.65	-0.59	-0.61	-0.62	0.42	0.75	-0.55	-0.5	-0.65	-0.81	-0.46		-0.66	-0.67	0.9	-0.69	0.09	0.79	-0.59	-0.7	-0.47	-0.69	-0.53
Common Stock Total Equity	0.95	-0.77	0.99	0.98	0.96	0.98	0.99	-0.91	-0.89	0.89	0.95	1.0	0.81	0.94	-0.66		0.75	-0.68	1.0	-0.57	-0.5	0.96	0.73	0.94	1.0	0.53
Common Stock Shares Outstanding	0.62	-0.6	0.82	0.79	0.62	0.67	0.73	-0.59	-0.84	0.67	0.67	0.74	0.88	0.6	-0.67	0.75		-0.53	0.79	0.03	-0.35	0.62	0.92	0.6	0.8	0.92
Non Current Liabilities Total	-0.58	0.11	-0.63	-0.58	-0.71	-0.71	-0.64	0.42	0.61	-0.41	-0.51	-0.67	-0.62	-0.56	0.9	-0.68	-0.53		-0.67	0.37	0.95	-0.71	-0.52	-0.57	-0.68	-0.39
Other Current Assets	0.94	-0.78	1.0	0.99	0.94	0.97	0.99	-0.91	-0.93	0.9	0.95	0.99	0.85	0.92	-0.69	1.0	0.79	-0.67		-0.51	-0.48	0.94	0.77	0.92	1.0	0.57
Other Stockholder Equity	-0.72	0.41	-0.44	-0.47	-0.73	-0.67	-0.61	0.64	0.23	-0.47	-0.64	-0.59	-0.09	-0.74	0.09	-0.57	0.03	0.37	-0.51		0.31	-0.73	0.06	-0.74	-0.51	0.14
Total Liab	-0.38	-0.16	-0.44	-0.36	-0.54	-0.55	-0.44	0.17	0.36	-0.16	-0.28	-0.47	-0.38	-0.36	0.79	-0.5	-0.35	0.95	-0.48	0.31		-0.54	-0.28	-0.36	-0.49	-0.23
Net Invested Capital	0.98	-0.7	0.91	0.9	1.0	0.99	0.97	-0.9	-0.8	0.8	0.94	0.97	0.7	0.98	-0.59	0.96	0.62	-0.71	0.94	-0.73	-0.54		0.61	0.98	0.95	0.42
Property Plant And Equipment Gross	0.63	-0.67	0.81	0.79	0.61	0.65	0.72	-0.66	-0.93	0.7	0.69	0.74	0.96	0.61	-0.7	0.73	0.92	-0.52	0.77	0.06	-0.28	0.61		0.61	0.78	0.78
Total Current Assets	1.0	-0.81	0.9	0.9	0.98	0.97	0.97	-0.96	-0.79	0.84	0.98	0.96	0.69	1.0	-0.47	0.94	0.6	-0.57	0.92	-0.74	-0.36	0.98	0.61		0.93	0.42
Capital Stock	0.94	-0.77	1.0	0.98	0.95	0.97	0.99	-0.9	-0.92	0.88	0.95	0.99	0.85	0.92	-0.69	1.0	0.8	-0.68	1.0	-0.51	-0.49	0.95	0.78	0.93		0.58
Non Current Liabilities Other	0.44	-0.44	0.6	0.57	0.42	0.46	0.51	-0.39	-0.63	0.49	0.48	0.53	0.73	0.42	-0.53	0.53	0.92	-0.39	0.57	0.14	-0.23	0.42	0.78	0.42	0.58

Click cells to compare fundamentals

Immuneering Corp Account Relationship Matchups

Immuneering Corp fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	38.4M	166.7M	122.4M	102.6M	118.0M	97.7M
Short Long Term Debt Total	621.1K	5.4M	4.8M	4.5M	4.0M	5.1M
Other Current Liab	699.0K	4.0M	4.5M	5.4M	6.2M	3.3M
Total Current Liabilities	2.3M	5.6M	8.1M	7.8M	9.0M	5.3M
Total Stockholder Equity	(22.5M)	156.0M	109.9M	90.6M	104.2M	72.0M
Property Plant And Equipment Net	677.5K	6.1M	5.8M	5.4M	6.2M	4.0M
Net Debt	(36.5M)	(69.5M)	(67.8M)	(54.9M)	(49.4M)	(51.9M)
Retained Earnings	(25.7M)	(59.3M)	(109.8M)	(163.3M)	(146.9M)	(139.6M)
Accounts Payable	1.5M	1.4M	3.2M	2.1M	2.4M	1.9M
Cash	37.1M	74.9M	72.6M	59.4M	68.3M	56.7M
Non Current Assets Total	691.8K	14.4M	13.6M	13.5M	15.5M	9.3M
Non Currrent Assets Other	(31.9K)	102.1K	743.7K	1.0M	1.2M	1.2M
Cash And Short Term Investments	37.1M	149.2M	105.5M	85.7M	98.5M	86.1M
Liabilities And Stockholders Equity	38.4M	166.7M	122.4M	102.6M	118.0M	97.7M
Non Current Liabilities Total	58.6M	5.1M	4.5M	4.2M	3.7M	3.6M
Capital Lease Obligations	621.1K	5.4M	4.8M	4.5M	5.1M	3.4M
Other Current Assets	141.0K	2.9M	3.2M	3.4M	3.9M	2.1M
Other Stockholder Equity	61.4M	(166.5B)	(122.1B)	253.8M	228.4M	239.8M
Total Liab	60.9M	10.7M	12.5M	12.0M	10.8M	18.7M
Net Invested Capital	(22.5M)	156.0M	109.9M	90.6M	104.2M	72.0M
Property Plant And Equipment Gross	677.5K	807.2K	1.4M	6.1M	7.0M	7.4M
Total Current Assets	37.7M	152.3M	108.7M	89.1M	102.4M	88.4M
Accumulated Other Comprehensive Income	(58.1M)	(49.0K)	(30.1K)	(778.0)	(894.7)	(939.43)
Net Working Capital	35.5M	146.7M	100.7M	81.2M	93.4M	83.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immuneering Net Interest Income vs Net Income From Continuing Ops Analysis

Net Interest Income vs Net Income From Continuing Ops

Net Interest Income vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Net Interest Income

Net Income From Continuing Ops

Immuneering Corp fundamental ratios Correlations

Immuneering Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immuneering Corp fundamental ratios Accounts

Also Currently Popular

Additional Tools for Immuneering Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Other Current Liab
Capital Stock	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net

Cash	- 0.99	Net Debt
Non Currrent Assets Other	- 0.97	Retained Earnings
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Net Debt	- 0.96	Total Assets
Net Debt	- 0.95	Property Plant And Equipment Net